Omini develops a biosensor platform that enables decentralized blood testing through multi-sensing blood testing strips and a connected reader for real-time data transmission. This technology facilitates near-patient and self-testing, improving chronic disease management by providing timely insights for both patients and healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Current blood testing methods often require visits to centralized labs, leading to delays in obtaining results and challenges for patients with chronic conditions who need frequent monitoring. This can hinder timely adjustments to treatment plans and proactive management of their health.
Solution
OMINI provides a biosensor platform for decentralized blood testing, enabling patients and healthcare providers to access real-time data outside of traditional lab settings. The system combines multi-sensing blood testing strips with a portable, connected reader for immediate data transmission and analysis. This technology facilitates near-patient and self-testing, empowering individuals to actively participate in their chronic disease management and enabling more responsive clinical decision-making. The platform aims to shift the focus from reactive intervention to proactive, preventive care.
Target Audience
The primary target audience includes patients with chronic diseases requiring frequent blood monitoring, healthcare providers seeking to improve patient outcomes through timely data insights, and organizations focused on preventive care and decentralized diagnostics.
Features
- Multi-sensing blood testing strips for simultaneous analysis of various biomarkers
- Portable, connected reader for on-the-spot data acquisition and transmission
- Secure data transmission to a clinical application for data visualization and analysis
- Patented biosensor technology for accurate and reliable results
- Enables near-patient and self-testing capabilities